Differential expression of clusterin according to histological type of endometrial carcinoma

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 222-229

  Ahn, Hee Jung ^a   Bae, Jeehyeon ^a   Lee, Sunyoung ^a   Ko, Jung Eun ^a   Yoon, Seongmin ^a   Kim, Seung Jo ^a   Sakuragi, Noriaki ^b  

^a CHA University   (South Korea)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Clusterin; Endometrial carcinoma; Endometrioid type; Estrogen; Papillary serous type

Indexed keywords

CLUSTERIN; ESTRADIOL; MESSENGER RNA; PARAFFIN;

ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CLUSTERIN; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL;

EID: 47249128504     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.010     Document Type: Article

References (34)

1. Rosenberg M.E., and Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27 (1995) 633-645
2. Trougakos I.P., and Gonos E.S. Clusterin: apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34 (2002) 1430-1448
3. Trougakos I.P., So A., Jansen B., Gleave M.E., and Gonos E.S. Silencing expression of the clusterin: apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64 (2004) 1834-1842
4. Leskov K.S., Klokov D.Y., Li J., Kinsella T.J., and Boothman D.A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278 (2003) 11590-11600
5. Pucci S., Bonanno E., Pichiorri F., Angeloni C., and Spagnoli L.G. Modulation of different clusterin: isoforms in human colon tumorigenesis. Oncogene 23 (2004) 2298-2304
6. Steinberg J., Oyasu R., Lang S., Sintich S., Rademaker A., Lee C., et al. Intracellular levels of SGP-2 (clusterin): correlate with tumor grade in prostate cancer. Clin Cancer Res 3 (1997) 1707-1711
7. Parczyk K., Pilarsky C., Rachel U., and Koch-Brandt C. Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res Clin Oncol 120 (1994) 186-188
8. July L.V., Beraldi E., So A., Fazli L., Evans K., English J.C., et al. Nucleotide-based therapies targeting clusterin: chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer TheMol Cancer Ther 3 (2004) 223-232
9. Hough C.D., Cho K.R., Zonderman A.B., Schwartz D.R., and Morin P.J. Coordinately up-regulated genes in ovarian cancer. Cancer Res 61 (2001) 3869-3876
10. Redondo M., Villar E., Torres-Munoz J., Tellez T., Morell M., and Petito C.K. Overexpression of clusterin in human breast carcinoma. Am J Pathol 157 (2000) 393-399
11. Scaltriti M., Brausi M., Amorosi A., Caporali A., D'Arca D., and Astancolle S. Clusterin (SGP-2, ApoJ): expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer 108 (2004) 23-30
12. Zhang L.Y., Ying W.T., Mao Y.S., He H.Z., Liu Y., Wang H.X., et al. Loss of clusterin: both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 9 (2003) 650-654
13. Xie M.J., Motoo Y., Su S.B., Mouri H., Ohtsubo K., Matsubara F., et al. Expression of clusterin: in human pancreatic cancer. Pancreas 25 (2002) 234-238
14. Santilli G., Aronow B.J., and Sala A. Essential requirement of apolipoprotein J (clusterin): signaling for IkappaB expression and regulation of NF-kappaB activity. J Biol Chem 278 (2003) 38214-38219
15. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 (1983) 10-17
16. Hendrickson M., Ross J., Eifel P., Martinez A., Kempson R., Hendrickson M., et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6 (1982) 93-108
17. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 54 (1994) 264-268
18. Silva E.G., and Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 3 (1990) 120-128
19. Goodfellow P.J., and Mutch D.G. Molecular genetics of endometrial cancers. In: Gershenson D., and Mcguire W. (Eds). Gynecologic Cancer: Controversies in management (2004), Elsevier, St.Louis 229-239
20. Brown T.L., Moulton B.C., Baker V.V., Mira J., and Harmony J.A. Expression of apolipoprotein J in the uterus is associated with tissue remodeling. Biol Reprod 52 (1995) 1038-1049
21. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451-486
22. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
23. Webb D.K., Moulton B.C., Webb D.K., Moulton B.C., and Khan S.A. Estrogen induces expression of c-jun and jun-B protooncogenes in specific rat uterine cells. Endocrinology 133 (1993) 20-28
24. Hyder S.M., Nawaz Z., Chiappetta C., Yokoyama K., and Stancel G.M. The proooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem 270 (1995) 8506-8513
25. Tenniswood M., Wang Z., Lakins J., Morrissey C., O'Sullivan J., and Tang H. Clusterin: in the male reproductive tract. J Androl 19 (1998) 508-516
26. Wong P., Pineault J., Lakins J., Taillefer D., Leger J., Wang C., et al. Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 268 (1993) 5021-5031
27. Michel D., Chatelain G., North S., and Brun G. Stress-induced transcription of the clusterin: ApoJ gene. Biochem J 328 (1997) 45-50
28. Yang X., Dale E.C., Diaz J., and Shyamala G. Estrogen dependent expression of heat shock transcription factor: implications for uterine synthesis of heat shock proteins. J Steroid Biochem Mol Biol 52 (1995) 415-419
29. Nanbu K., Konishi I., Komatsu T., Mandai M., Yamamoto S., Kuroda H., et al. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 77 (1996) 330-338
30. Humphreys D.T., Carver J.A., Easterbrook-Smith S.B., Wilson M.R., Humphreys D.T., and Carver J.A. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274 (1999) 6875-6881
31. Cervellera M., Raschella G., Santilli G., Tanno B., Ventura A., Mancini C., et al. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J Biol Chem 275 (2000) 21055-21060
32. Sintich S.M., Steinberg J., Kozlowski J.M., Lee C., Pruden S., Sayeed S., et al. Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin). Prostate 39 (1999) 87-93
33. Miyake H., Hara I., Kamidono S., Gleave M.E., and Eto H. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol Rep 10 (2003) 469-473
34. Xie D., Lau S.H., Sham J.S., Wu Q.L., Fang Y., Liang L.Z., et al. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma. Cancer 103 (2005) 277-283